BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|January 1, 2006
- Volume 0 0
Resealable and Nultraviolet Ultraviolet (UV) Inhibitant Bags
Advertisement
EPS Inc (Ivyland, Pa) recently expanded its line of Resealable and Nultraviolet UV Inhibitant Bags. The company now stocks a full array of imprinted bags in a variety of sizes for the protection and transfer of medication. The product is available clear, with white writing blocks or with a variety of color imprints. Freeze, IV, Stat, Refrigerate, and Return to Pharmacy are a sample of the printed bags available. EPS Inc also stocks resealable narcotic return envelopes, as well as chemotherapy, biohazard, and laboratory specimen bags. These bags complement the assortment of Nultraviolet UV Inhibitant Bags. For more information, visit www.medi-dose.com, or call 800-523-8966.
Articles in this issue
almost 21 years ago
High Alert Insulin Binalmost 21 years ago
Hydase (hyaluronidase injection, USP)almost 21 years ago
Humira (adalimumab)almost 21 years ago
INVANZ (ertapenem for injection)almost 21 years ago
Compounding HOTLINEalmost 21 years ago
Customer Guilty of Prescription Fraud by Supporting Friendalmost 21 years ago
Counterfeit Drugs: A Life-or-Death Problemalmost 21 years ago
Qui Tam Lawsuits Blow the Whistle on PBMsalmost 21 years ago
Can You Read These Rxs?almost 21 years ago
What You Need to Know About Alzheimer's DiseaseAdvertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
What the 2025-2030 Dietary Guidelines Mean for Heart Health
5